The legendary food service company in Reserve, St John the Baptist Parish in Louisiana celebrated 100 years in business on ...

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF ...

The drug enhances the flow of blood through the lungs, allowing children with PAH to breathe and improve their ability to engage in physical activity.

Natco Pharma share price stands at ₹795.65 as of 11.45 am on March 3, 2025. This reflects a gain of 3.22% from the previous ...

Since last week, Natco Pharma’s shares have plunged over 30%, after the company posted weak Q3 earnings, on account of the absence of sales of Revlimid during the quarter. The company reported a ...

NATCO Pharma’s stock faced a sharp sell-off, extending its losing streak to the fifth consecutive session after the pharmaceutical company reported a 37.75 per cent year-on-year (YoY ...

Natco Pharma Q3 Results 2025:Natco Pharma declared their Q3 results on 12 Feb, 2025, revealing a significant decline in both revenue and profit. The company reported a profit of ₹133 crore ...

In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr. Reddy's Laboratories are shifting their focus to a promising new frontier ...

Natco Pharma, a Telangana-based pharmaceutical company, saw its shares plummet to the abyss, losing double digits (over 19 per cent) in the intraday trade on Thursday, February 13. This major ...

Natco Pharma has announced that G. Vasan has been designated as Vice President - (Operations) of the Company w.e.f. 27th February, 2025.G. Vasan is a Postgraduate in Chemistry and having 35+ ...

Telangana: Natco Pharma has appointed Bhimrao Dattu Jadhav as Senior Vice President - Operations (Formulations) for Pharma ...